Skip to main content
. 2015 Jan 22;2015(1):CD010381. doi: 10.1002/14651858.CD010381.pub2

1. Results reported from included studies.

Outcome Zapol 1979* Morris 1994*† Peek 2009 Bein 2013§
Intervention/Population VA ECMO + ventilation/ARDS patients VV ECCO2‐R + ventilation/ARDS patients VV ECMO + ventilation/ARDS patients AV ECCO2‐R + ventilation/ARDS patients
All‐cause mortality (number (%))
Intervention group (IG) vs control group (CG)
38 of 42 (91) vs 44 of 48 (92) 14 of 21 (66) vs 11 of 19 (57) 33 of 90 (37) vs 45 of 90 (50) 7 of 40 (17.5) vs 6 of 39 (15.4)
All‐cause mortality difference IG vs CG
 (RR, 95% CI) RR 0.99, 95% CI 0.87 to 1.12
Not statistically significant
RR 1.15, 95% CI 0.71 to 1.88
Not statistically significant
RR 0.73, 95% CI 0.52 to 1.03
Not statistically significant
RR 1.14, 95% CI 0.42 to 3.08
Not statistically significant
Length of hospital stay (LOS) days (± SD)a
IG vs CG
Not reported 26.9 (4.9) vs 28.8 (5.7)
Not statistically significant
35 (15.6 ‐74) vs 17 (4.8 ‐45.3)b 46.7 (33) vs 35.1 (17)
Not statistically significant
Survival to discharge (number (%))
IG vs CG
Not reported 7 (33)c vs 8 (42)c
Not statistically significant
Not reported 33 (82.5) vs 33 (84.6)
Not statistically significant
Disability as reported by study authors Normal lung function: 7 of 8 (both groups)
No limitations in daily activities for all survivors
Not reported No severe disabilityd at 6 months:
IG: 57 of 90 (63%)
CG: 41 of 87 (47%)
Statistically significant
Not reported
Adverse outcomes IG and CG:
septicaemia (20%), pneumothorax (45%)
Not statistically significant
IG: lower blood platelet and white blood cell concentration and greater blood/ plasma infusion reported with 1 to 2.5 liters
Statistically significant
Major complicationse IG = 34 vs CG = 16
Not statistically significant
Non‐brain haemorrhage IG = 21 vs CG = 0
Statistically significant
IG: transfusion exceeded 0.8 L/d in 10 patients and led to bypass disconnection in 7 patients
IG = 2 vs CG = 0
  • 1 was death due to mechanical failure of oxygen supply during ambulance

  • Vessel perforation during cannulation

IG = 3 (7.5%) vs CG =0
  • 1 had transient ischaemia of the lower limb

  • 2 patients developed a "false" aneurysm from arterial cannulation


Transfusion of blood unitsf
IG = 3.7 units vs CG = 1.5
Statistically significant

ARDS = acute respiratory distress syndrome.

AV ECCO2‐R = arteriovenous extracorporeal membrane carbon dioxide removal.

VV ECCO2‐R = veno‐venous extracorporeal membrane carbon dioxide removal.

aSD = Standard deviation.

b LOS days (interquartile range (IQR)).

cSurvival at 30 days after randomization.

dSevere disability was determined by the first 2 items of the EQ‐5D survey (item Mobility = unable to walk around, in addition to item Personal Care = unable to wash or dress).

eCentral nervous system (CNS), peripheral vascular and other.

fRed blood cell units until day 10.

*The ECMO configuration and respirator settings in the ECMO group and/or the control group are outdated.

The trial was stopped after 40 participants.

3 patients in the control group had unknown disability status. If the 3 patients were severely disabled, RR of the primary outcome (death or severe disability) was 0.67 (95% CI 0.48 to 0.94; P value 0.017); it was 0.72 (95% CI 0.51 to 1.01; P value 0.051) if they were not severely disabled. Only 68 (75%) of participants randomly assigned to the intervention group actually received ECMO.

§Feasability study that used pump‐free avECCO2‐R to achieve very low tidal volume (3 mL/kg) in established ARDS compared with standard mechanical ventilation (6 mg/kg).